Annual Accounts Payable
$3.89 M
+$1.33 M+52.07%
December 31, 2022
Summary
- As of February 9, 2025, TALS annual accounts payable is $3.89 million, with the most recent change of +$1.33 million (+52.07%) on December 31, 2022.
- During the last 3 years, TALS annual accounts payable has risen by +$3.22 million (+482.76%).
Performance
TALS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$2.93 M
-$450.00 K-13.30%
June 30, 2023
Summary
- As of February 9, 2025, TALS quarterly accounts payable is $2.93 million, with the most recent change of -$450.00 thousand (-13.30%) on June 30, 2023.
- Over the past year, TALS quarterly accounts payable has increased by +$859.00 thousand (+41.40%).
Performance
TALS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TALS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +52.1% | +41.4% |
| 3 y3 years | +482.8% | - |
| 5 y5 years | +482.8% | - |
TALS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -34.2% | -24.5% | -29.3% |
| 5 y | 5-year | at high | -82.8% | -24.5% | -73.9% |
| alltime | all time | at high | -82.8% | -24.5% | -73.9% |
Talaris Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $2.93 M(-13.3%) |
| Mar 2023 | - | $3.38 M(-12.9%) |
| Dec 2022 | $3.89 M(+52.1%) | $3.89 M(+82.2%) |
| Sep 2022 | - | $2.13 M(+2.8%) |
| Jun 2022 | - | $2.08 M(-40.5%) |
| Mar 2022 | - | $3.48 M(+36.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $2.56 M(+233.2%) | $2.56 M(+116.2%) |
| Sep 2021 | - | $1.18 M(-6.6%) |
| Jun 2021 | - | $1.26 M(+64.5%) |
| Mar 2021 | - | $769.00 K(+0.3%) |
| Dec 2020 | $767.00 K(+15.0%) | - |
| Dec 2020 | - | $767.00 K |
| Dec 2019 | $667.00 K | - |
FAQ
- What is Talaris Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Talaris Therapeutics?
- What is Talaris Therapeutics annual accounts payable year-on-year change?
- What is Talaris Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Talaris Therapeutics?
- What is Talaris Therapeutics quarterly accounts payable year-on-year change?
What is Talaris Therapeutics annual accounts payable?
The current annual accounts payable of TALS is $3.89 M
What is the all time high annual accounts payable for Talaris Therapeutics?
Talaris Therapeutics all-time high annual accounts payable is $3.89 M
What is Talaris Therapeutics annual accounts payable year-on-year change?
Over the past year, TALS annual accounts payable has changed by +$1.33 M (+52.07%)
What is Talaris Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TALS is $2.93 M
What is the all time high quarterly accounts payable for Talaris Therapeutics?
Talaris Therapeutics all-time high quarterly accounts payable is $3.89 M
What is Talaris Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TALS quarterly accounts payable has changed by +$859.00 K (+41.40%)